3. Results
Among the 144 HD patients who met the inclusion and exclusion criteria, 96 patients gave their consent to participate in the study. After the enrollment was finished, there were 50 patients in the treatment group (oral MK-7 375 mcg/day) and 46 patients in the control group as shown in 